174 related articles for article (PubMed ID: 16026300)
1. Pharmacological management of acutely agitated schizophrenic patients.
San L; Arranz B; Escobar R
Curr Pharm Des; 2005; 11(19):2471-7. PubMed ID: 16026300
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute agitation in psychotic disorders.
Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
[TBL] [Abstract][Full Text] [Related]
3. Clinical perspectives on atypical antipsychotics for treatment of agitation.
Caine ED
J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Brook S
J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological control of acute agitation: focus on intramuscular preparations.
Zimbroff DL
CNS Drugs; 2008; 22(3):199-212. PubMed ID: 18278976
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of acute agitation.
Battaglia J
Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
San L; Estrada G; Oudovenko N; Vieta E
BMC Psychiatry; 2017 Apr; 17(1):126. PubMed ID: 28376877
[TBL] [Abstract][Full Text] [Related]
8. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
[TBL] [Abstract][Full Text] [Related]
10. Sedation in acute and chronic agitation.
Levy RH
Pharmacotherapy; 1996; 16(6 Pt 2):152S-159S; discussion 166S-168S. PubMed ID: 8947999
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics for acute agitation. New intramuscular options offer advantages.
Citrome L
Postgrad Med; 2002 Dec; 112(6):85-8, 94-6. PubMed ID: 12510449
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of psychotic agitation.
Currier GW; Trenton A
CNS Drugs; 2002; 16(4):219-28. PubMed ID: 11945106
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of acutely agitated pediatric patients.
Sonnier L; Barzman D
Paediatr Drugs; 2011 Feb; 13(1):1-10. PubMed ID: 21162596
[TBL] [Abstract][Full Text] [Related]
15. Evidence-Based Review Of Pharmacotherapy For Acute Agitation. Part 2: Safety.
Zun LS
J Emerg Med; 2018 Apr; 54(4):522-532. PubMed ID: 29433934
[TBL] [Abstract][Full Text] [Related]
16. Injectable atypical antipsychotics for agitation in borderline personality disorder.
Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
[TBL] [Abstract][Full Text] [Related]
18. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.
Bosanac P; Hollander Y; Castle D
Australas Psychiatry; 2013 Dec; 21(6):554-62. PubMed ID: 23996795
[TBL] [Abstract][Full Text] [Related]
19. A review of agitation in mental illness: treatment guidelines and current therapies.
Marder SR
J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
[TBL] [Abstract][Full Text] [Related]
20. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
